Home › Merkel Cell Carcinoma › Massachusetts › Boston
Merkel Cell Carcinoma clinical trials in Boston, MA
5 studies for Merkel Cell Carcinoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- Tufts Medical Center, Boston
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RecruitingPhase 1
- Massachusetts General Hospital, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Massachusetts General Hospital Cancer Center, Boston
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RecruitingPhase 2/3
- Dana-Farber Cancer Institute, Boston
TIL Therapy in cSCC and MCC
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Merkel Cell Carcinoma trials in other cities
- Houston, TX6 studies
- San Antonio, TX4 studies
- New York City, NY4 studies
- Tampa, FL4 studies
- Washington, DC3 studies
- Nashville, TN3 studies
- St. Louis, MO3 studies
- Queens, NY3 studies
- Los Angeles, CA3 studies
- Pittsburgh, PA3 studies
- Miami, FL3 studies
- Seattle, WA3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer60 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.